9
Participants
Start Date
April 30, 2021
Primary Completion Date
May 16, 2022
Study Completion Date
May 16, 2022
Dociparstat
Dociparstat is a glycosaminoglycan derived from porcine heparin.
Control
0.9% Normal Saline
Mount Sanai School of Medicine, New York
New York Medical College, Hawthorne
University of Virginia Cancer Center, Charlottesville
East Carolina University Vidant Medical Center, Greenville
Spartanburg Medical Gibbs Cancer Center, Spartanburg
Norton Cancer Institute, St. Matthews Campus, Louisville
Gabrail Cancer Center, Canton
Henry Ford Health System, Detroit
Allina Health System / Virginia Piper Cancer Institute, Minneapolis
University of Kansas Cancer Center, Westwood
Tulane University School of Medicine, New Orleans
Baylor, Dallas
University of Utah / Huntsman Cancer Institute, Salt Lake City
UC Irvine Medical Center, Orange
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY